Publikationstyp: Beitrag in wissenschaftlicher Zeitschrift
Art der Begutachtung: Peer review (Publikation)
Titel: Susceptibility to 5-aminolevulinic acid based photodynamic therapy in WHO I meningioma cells corresponds to ferrochelatase activity
Autor/-in: Hefti, Martin
Holenstein, Fabian
Albert, Ina
Looser, Herbert
Luginbühl, Vera
DOI: 10.1111/j.1751-1097.2010.00821.x
Erschienen in: Photochemistry and Photobiology
Band(Heft): 87
Heft: 1
Seite(n): 235
Seiten bis: 241
Erscheinungsdatum: 2011
Verlag / Hrsg. Institution: Wiley
ISSN: 0031-8655
1751-1097
Sprache: Englisch
Schlagwörter: Meningioma; Photodynamic therapy; 5-Aminolevulinic acid; Brain tumor
Fachgebiet (DDC): 540: Chemie
Zusammenfassung: 5-Aminolevulinic acid (5-ALA) is a natural precursor of protoporphyrin IX (PpIX), which can be used as a photosensitizer in photodynamic therapy (PDT). Accumulation of PpIX in benign meningioma cells has been observed previously, its exploitation for PDT, however, was discouraged by inconsistent results. To evaluate PDT for benign meningiomas, we investigated PpIX synthesis in two human meningioma cell lines (HBL-52 and BEN MEN-1), their respective extracellular loss of PpIX and corresponding ferrochelatase (FECH) activity as well as their susceptibility to PDT. We demonstrated PpIX production after 5-ALA administration and minor loss to the extracellular space in both cell lines. However, significantly more (up two five times) PpIX was accumulated in BEN-MEN-1 as compared to HBL-52 cells. FECH activity was 2.7 fold higher in HBL-52 compared to BEN-MEN-1 cells and accordingly higher FECH levels could be shown in HBL-52 cells by western blot analysis. BEN MEN-1 cells were much more sensitive to PDT and cells could be almost completely killed by irradiation doses of 2 J cm-2, whereas HBL-52 showed only an insuffient response at this irradiation dose. We conclude that differences in intracellular PpIX concentrations between HBL-52 and BEN-MEN-1 benign menigioma cells were mainly due to differences in FECH activity and that these differences correspond to their susceptibility to 5-ALA induced PDT.
URI: https://digitalcollection.zhaw.ch/handle/11475/12933
Volltext Version: Publizierte Version
Lizenz (gemäss Verlagsvertrag): Lizenz gemäss Verlagsvertrag
Departement: Life Sciences und Facility Management
Organisationseinheit: Institut für Chemie und Biotechnologie (ICBT)
Enthalten in den Sammlungen:Publikationen Life Sciences und Facility Management

Dateien zu dieser Ressource:
Es gibt keine Dateien zu dieser Ressource.
Zur Langanzeige
Hefti, M., Holenstein, F., Albert, I., Looser, H., & Luginbühl, V. (2011). Susceptibility to 5-aminolevulinic acid based photodynamic therapy in WHO I meningioma cells corresponds to ferrochelatase activity. Photochemistry and Photobiology, 87(1), 235–241. https://doi.org/10.1111/j.1751-1097.2010.00821.x
Hefti, M. et al. (2011) ‘Susceptibility to 5-aminolevulinic acid based photodynamic therapy in WHO I meningioma cells corresponds to ferrochelatase activity’, Photochemistry and Photobiology, 87(1), pp. 235–241. Available at: https://doi.org/10.1111/j.1751-1097.2010.00821.x.
M. Hefti, F. Holenstein, I. Albert, H. Looser, and V. Luginbühl, “Susceptibility to 5-aminolevulinic acid based photodynamic therapy in WHO I meningioma cells corresponds to ferrochelatase activity,” Photochemistry and Photobiology, vol. 87, no. 1, pp. 235–241, 2011, doi: 10.1111/j.1751-1097.2010.00821.x.
HEFTI, Martin, Fabian HOLENSTEIN, Ina ALBERT, Herbert LOOSER und Vera LUGINBÜHL, 2011. Susceptibility to 5-aminolevulinic acid based photodynamic therapy in WHO I meningioma cells corresponds to ferrochelatase activity. Photochemistry and Photobiology. 2011. Bd. 87, Nr. 1, S. 235–241. DOI 10.1111/j.1751-1097.2010.00821.x
Hefti, Martin, Fabian Holenstein, Ina Albert, Herbert Looser, and Vera Luginbühl. 2011. “Susceptibility to 5-Aminolevulinic Acid Based Photodynamic Therapy in WHO I Meningioma Cells Corresponds to Ferrochelatase Activity.” Photochemistry and Photobiology 87 (1): 235–41. https://doi.org/10.1111/j.1751-1097.2010.00821.x.
Hefti, Martin, et al. “Susceptibility to 5-Aminolevulinic Acid Based Photodynamic Therapy in WHO I Meningioma Cells Corresponds to Ferrochelatase Activity.” Photochemistry and Photobiology, vol. 87, no. 1, 2011, pp. 235–41, https://doi.org/10.1111/j.1751-1097.2010.00821.x.


Alle Ressourcen in diesem Repository sind urheberrechtlich geschützt, soweit nicht anderweitig angezeigt.